Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Asian Biomedicine
Volume 16 (2022): Numero 3 (June 2022)
Accesso libero
Uterine tumor resembling ovarian sex-cord tumor: case report and review of the literature
Rong Xu
Rong Xu
,
Liping Shao
Liping Shao
,
Wenling Zhang
Wenling Zhang
e
Zhi-Long Yang
Zhi-Long Yang
| 30 giu 2022
Asian Biomedicine
Volume 16 (2022): Numero 3 (June 2022)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Articolo
Immagini e tabelle
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Article Category:
Clinical report
Pubblicato online:
30 giu 2022
Pagine:
145 - 150
DOI:
https://doi.org/10.2478/abm-2022-0018
Parole chiave
case reports
,
fertility preservation
,
immunohistochemistry
,
surgery
,
uterine neoplasms
© 2022 Rong Xu et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Figure 1
Pelvic computed tomography image showing an unclear defined 11 cm pelvic mass without further abnormalities.
Figure 2
Magnetic resonance imaging and macroscopic findings. (A) T2-weighted image and (B) diffusion-weighted image depicting a high signal intensity in the uterine fibroid.
Figure 3
Dense long spindle cell configurations and hyaline stromal changes under hematoxylin and eosin staining. (A) 40× (scale bar 250 μm), (B) 100× (scale bar 100 μm), (C) 400× (scale bar 50 μm), and (D) 400× (scale bar 50 μm).
Figure 4
Immunohistochemistry of the UTROSCT. The tumor was positive for (A) CD10 (2+), (B) CD99 (3+), (C) CD34 (+), (D) desmin (3+), (E) ER (3+), (F) PR (3+), (G) SMA (3+), and (H) Ki67 (15%+); magnification: 100× (scale bar 100 μm). The antibodies used were as follows: anti-calretinin (catalog No. CCR-0221, Sainuote Biological Technology Co., China; 1:50); anti-CD10 (catalog No. C6D1; Sainuote Biological Technology; 1:50), anti-CD117 (catalog No. EP10, Sainuote Biological Technology; 1:50), anti-CD99 (clone: 013; catalog No. GT212302, Sainuote Biological Technology; 1:50), anti-CD34 (clone: QBend/10; Sainuote Biological Technology; 1:50), anti-D2-40 (catalog No. D2-40, Sainuote Biological Technology; 1:50), anti-desmin (catalog No. C3B7, Sainuote Biological Technology; 1:50), anti-ER (catalog No. FNab02822, Wuhan Feieng Biological Technology Co., China; 1:50), anti-PR (catalog No. YZK7169, Shanghai Yanzhun Biological Technology Co., China; 1:50), anti-SMA (catalog No. C1C1; Sainuote Biological Technology; 1:50), and anti-Ki67 (catalog No. C3G4, Sainuote Biological Technology; 1:50). ER, estrogen receptor; PR, progesterone receptor; SMA, α smooth muscle actin (actin α-2 (ACTA2)); UTROSCT, uterine tumor resembling ovarian sex-cord tumor.